Jianfeng Zhou
- Cancer Research top 10%
- MicroRNA in disease regulation 4
- Geriatrics and Gerontology top 10%
-
- Colorectal Cancer Treatments and Studies 6
- Cancer Cells and Metastasis 5
- Pancreatic and Hepatic Oncology Research 4
-
- Esophageal Cancer Research and Treatment 19
- Esophageal and GI Pathology 6
-
- Gastric Cancer Management and Outcomes 8
- Lung Cancer Diagnosis and Treatment 4
- Journals
- Journal of Biological Chemistry (2 papers)Journal of Clinical Oncology (1 paper)Oncogene (1 paper)
- Partner nations
- ChinaMacaoUnited States
In The Last Decade
Jianfeng Zhou
46 papers receiving 708 citations
Peers
Comparison fields: 5 of 81
- Cancer Research 185
- Geriatrics and Gerontology 31
- Oncology 195
- Developmental Neuroscience 23
- Biomaterials 60
Countries citing papers authored by Jianfeng Zhou
This map shows the geographic impact of Jianfeng Zhou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jianfeng Zhou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jianfeng Zhou more than expected).
Fields of papers citing papers by Jianfeng Zhou
This network shows the impact of papers produced by Jianfeng Zhou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jianfeng Zhou. The network helps show where Jianfeng Zhou may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Jianfeng Zhou, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2024 | 0 | |
| 4 | 2024 | 0 | |
| 5 | 2024 | 4 | |
| 6 | 2022 | 8 | |
| 7 | 2022 | 76 | |
| 8 | 2022 | 31 | |
| 9 | 2022 | 2 | |
| 10 | 2022 | 15 | |
| 11 | 2021 | 29 | |
| 12 | 2020 | 1 | |
| 13 | 2020 | 5 | |
| 14 | 2018 | 7 | |
| 15 | 2017 | 20 | |
| 16 | 2013 | 14 | |
| 17 | [Detection of isocitrate dehydrogenase 1 gene mutation in 205 AML patients and its clinical significance]. | 2012 | 1 |
| 18 | 2009 | 50 | |
| 19 | 2009 | 9 | |
| 20 | [Clinical analysis of amphotericin B in the treatment of invasive fungal infections in 121 patients with hematologic diseases]. | 2008 | 1 |
About Jianfeng Zhou
Jianfeng Zhou is a scholar working on Oncology, Cancer Research and Developmental Neuroscience, having authored 55 papers that have together received 716 indexed citations. Recurring topics across this work include Esophageal Cancer Research and Treatment (19 papers), Gastric Cancer Management and Outcomes (8 papers), Colorectal Cancer Treatments and Studies (6 papers), Esophageal and GI Pathology (6 papers), Cancer Cells and Metastasis (5 papers), MicroRNA in disease regulation (4 papers), Pancreatic and Hepatic Oncology Research (4 papers) and Lung Cancer Diagnosis and Treatment (4 papers). The work is most often cited by research in Cancer Research (185 citations), Geriatrics and Gerontology (31 citations) and Oncology (195 citations). Jianfeng Zhou has collaborated with scholars based in China, Macao and United States. Frequent co-authors include Yong Yuan, Yu‐Shang Yang, Siyuan Luan, Xiaoxi Zeng, Pinhao Fang, Xiaokun Li, Zhao Sun, Chunmei Bai, Qi‐Xin Shang and Hanlu Zhang. Their work appears in journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and Oncogene.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.